Skip to content
    Point 72 logo

    Point 72

    Point 72 is a seed to Series B stage investment firm. It has made 12 investments. Their most common stage is series-a (47% of deals). Average disclosed round size is $28.6M (across 13 rounds with reported amounts).

    Find people at Point 72 on Goldilocks AI

    Portfolio

    12

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    MK

    Macauley Kilbane

    Analyst

    MD

    Marissa Delikoura

    Investment Analyst

    TK

    Tomer Kogan

    Analyst

    SA

    Steven A. Cohen

    Chairman, Chief Executive Officer, and Co-Chief Investment Officer

    AC

    Anselm Cai

    Macro Trading Desk

    JW

    Jamie Waters

    Portfolio Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    15 investments
    CompanyRoundAmountDate
    Spore Biotechnologies logoSpore BiotechnologiesSeries A—Feb 2025
    Spore logoSporeSeries A$23MJan 2025
    Spore.Bio logoSpore.BioSeries A$23MJan 2025
    Hexa 3D logoHexa 3DSeries A$20.5MMar 2023
    LENZ Therapeutics logoLENZ TherapeuticsSeries B$83.5MJan 2023
    Unravel logoUnravelSeries D$50MJan 2022
    Privacera logoPrivaceraSeries A—Mar 2021
    Privacera logoPrivaceraSeries B$50MMar 2021
    ClickSwitch logoClickSwitchSeries B$21MSep 2020
    HHelloOfficeSeries A$20MJun 2020
    ClickSwitch logoClickSwitchSeries B$13MMay 2019
    AlphaFlow logoAlphaFlowSeed$4.1MSep 2017
    Privacera logoPrivaceraSeries B$50M—
    Anvilogic logoAnvilogicSeries A$10M—
    Crediverso logoCrediversoSeed$3.1M—

    Top Co-Investors

    Last updated: 20 October 2026